Mikael Frederiksen

20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mikael Frederiksen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study

Ben-Dali, Y., Hleuhel, M. H., da Cunha-Bang, C., Brieghel, C., Poulsen, C. B., Clasen-Linde, E., Bentzen, H. H. N., Frederiksen, H., Christiansen, I., Nielsen, L. H., Enggaard, L., Helleberg, M., Clausen, M., Frederiksen, M., Pedersen, R. S., Niemann, C. U. & Andersen, M. A., 7. Feb 2020, In : Leukemia and Lymphoma. p. 1-10 10 p.

Research output: Contribution to journalJournal articleResearchpeer-review

  • Strategies to improve patient-reported outcome completion rates in longitudinal studies

    Nielsen, L. K., King, M., Möller, S., Jarden, M., Andersen, C. L., Frederiksen, H., Gregersen, H., Klostergaard, A., Steffensen, M. S., Pedersen, P. T., Hinge, M., Frederiksen, M., Jensen, B. A., Helleberg, C., Mylin, A. K. & Abildgaard, N., Feb 2020, In : Quality of Life Research. 29, 2, p. 335-346

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • 37 Downloads (Pure)

    Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

    Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., Kruse, T. A. & 11 others, Thomassen, M., Mourits-Andersen, H. T., Severinsen, M. T., Jesper, S., Starklint, J., Møller, P., Neuberg, D. S., Kjær, L., Hasselbalch, H. C., Coleman Lindsley, R. & Mullally, A., 13. Nov 2019, In : Blood. 134, Supplement 1, 4202.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

    Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

    Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., Kruse, T. A. & 11 others, Thomassen, M., Mourits-Andersen, T., Severinsen, M. T., Jesper, S., Starklint, J., Møller, P., Neuberg, D. S., Kjær, L., Hasselbalch, H. C., Coleman Lindsley, R. & Mullally, A., 9. Dec 2019.

    Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

    IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL

    Andersen Patel, D., Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., Ellervik, C., el Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Lindholm Sørensen, A., Jesper, S., Starklint, J. & 4 others, de Stricker, K., Thomassen, M., Larsen, T. S. & Hasselbalch, H. C., Jun 2019, In : HemaSphere. 2019, PB2210.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

    Activities

    • 2 Conference organisation or participation
    • 2 Conference presentations
    • 1 Membership of commitees, commissions, boards, councils, associations, organisations, or similar
    • 1 Talks and presentations in private or public companies

    THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

    Trine Alma Knudsen (Lecturer), Dennis Lund Hansen (Other), Lucas Frans Ocias (Other), Ole Weiss Bjerrum (Other), Mette Brabrand (Other), Christina Ellervik (Other), Daniel el Fassi (Other), Mikael Frederiksen (Other), Lasse Kjær (Other), Thomas Kielsgaard Kristensen (Other), Torben A Kruse (Guest lecturer), Hans Torben Mourits-Andersen (Other), Peter Møller (Other), Ulrik Malthe Overgaard (Other), Dustin Andersen Patel (Other), Marianne Tang Severinsen (Other), Vibe Skov (Other), Anders Lindholm Sørensen (Other), Stentoft Jesper (Other), Jørn Starklint (Other), Karin de Stricker (Other), Mads Thomassen (Other), Thomas Stauffer Larsen (Guest lecturer), C Hasselbalc Hans (Other)
    16. Jun 2019

    Activity: Talks and presentationsConference presentations

    Strategier til forbedring af patient-reported outcomes data komplethed

    Lene Kongsgaard Nielsen (Guest lecturer), Henrik Frederiksen (Guest lecturer), Mikael Frederiksen (Guest lecturer)
    15. Mar 2019

    Activity: Talks and presentationsConference presentations

    Der Patient mit Blutbildveränderungen in der hausärtzlichen Praxis.

    Mikael Frederiksen (Lecturer)
    17. Nov 2012

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Kræftstyregruppen ved Sygehus Sønderjylland (External organisation)

    Mikael Frederiksen (Member)
    2012 → …

    Activity: MembershipMembership of commitees, commissions, boards, councils, associations, organisations, or similar

    53rd ASH annual meeting

    Mikael Frederiksen (Participant)
    9. Dec 2011

    Activity: Attending an eventConference organisation or participation